{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:06:22Z","timestamp":1760731582175,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["T32-DK07658"],"award-info":[{"award-number":["T32-DK07658"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Universal newborn screening changed the way medical providers think about the presentation of cystic fibrosis (CF). Before implementation of universal screening, it was common for children with CF to present with failure to thrive, nutritional deficiencies, and recurrent infections. Now, nearly all cases of CF are diagnosed by newborn screening shortly after birth before significant symptoms develop. Therefore, providers often do not consider this illness in the setting of a normal newborn screen. Newborn screening significantly decreases the risk of complications in early childhood, yet definitive testing should be pursued if a patient with negative newborn screening presents with symptoms consistent with CF, including severe failure to thrive, metabolic alkalosis due to significant salt losses, or recurrent respiratory infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present a case of a 6-month-old infant male with kwashiorkor, severe edema, multiple vitamin deficiencies, hematemesis secondary to coagulopathy, and diffuse erythematous rash, all secondary to severe pancreatic insufficiency. His first newborn screen had an immunoreactive trypsinogen (IRT) value below the state cut-off value, so additional testing was not performed, and his growth trajectory appeared reassuring. He was ultimately diagnosed with CF by genetic testing and confirmatory sweat chloride testing, in the setting of his parents being known CF carriers and his severe presentation being clinically consistent with CF. Acutely, management with supplemental albumin, furosemide, potassium, and vitamin K was initiated to correct the presenting hypoalbuminemia, edema, and coagulopathy. Later, pancreatic enzyme supplementation and additional vitamins and minerals were added to manage ongoing deficiencies from pancreatic insufficiency. With appropriate treatment, his vitamin deficiencies and edema resolved, and his growth improved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Due to universal newborn screening, symptomatic presentation of CF is rare and presentation with kwashiorkor is extremely rare in resource-rich communities. The diagnosis of CF was delayed in our patient because of a normal newborn screen and falsely reassuring growth, which after diagnosis was determined to be secondary to severe edematous malnutrition. This case highlights that newborn screening is a useful but imperfect tool. Clinicians should continue to have suspicion for CF in the right clinical context, even in the setting of normal newborn screen results.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.1083155","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T18:07:33Z","timestamp":1673028453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Cystic fibrosis with kwashiorkor: A rare presentation in the era of universal newborn screening"],"prefix":"10.3389","volume":"10","author":[{"given":"Annemarie G.","family":"Wolfe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie P.","family":"Gilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie W.","family":"Waldrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey B.","family":"Gumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Haemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordana E.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/ppul.24165","article-title":"Clinical outcomes in U.S. Infants with cystic fibrosis from 2001 to 2012","volume":"53","author":"Hoch","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijns8030038","article-title":"Newborn screening for cystic fibrosis: a qualitative study of successes and challenges from universal screening in the United States","volume":"8","author":"Sontag","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"B3","doi-asserted-by":"publisher","first-page":"608821","DOI":"10.3389\/fped.2020.608821","article-title":"Early diagnosis and intervention in cystic fibrosis: imagining the unimaginable","volume":"8","author":"Coverstone","year":"2020","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/23120541.00109-2017","article-title":"Early diagnosis from newborn screening maximises survival in severe cystic fibrosis","volume":"4","author":"Tridello","year":"2018","journal-title":"ERJ Open Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1136\/archdischild-2011-300449","article-title":"Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre","volume":"96","author":"Dijk","year":"2011","journal-title":"Arch Dis Child"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jpeds.2005.08.034","article-title":"Complications associated with symptomatic diagnosis in infants with cystic fibrosis","volume":"147","author":"Accurso","year":"2005","journal-title":"J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpeds.2016.10.045","article-title":"Differences in outcomes between early and late diagnosis of cystic fibrosis in the newborn screening era","volume":"181","author":"Coffey","year":"2017","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jpeds.2008.04.061","article-title":"Newborn screening for cystic fibrosis: a lesson in public health disparities","volume":"153","author":"Ross","year":"2008","journal-title":"J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.yapd.2014.03.002","article-title":"Advances in the diagnosis and treatment of cystic fibrosis","volume":"61","author":"Martiniano","year":"2014","journal-title":"Adv Pediatr"},{"year":"","key":"B10"},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/adc.2005.085084","article-title":"Newborn screening for cystic fibrosis: do we need a second IRT?","volume":"91","author":"Price","year":"2006","journal-title":"Arch Dis Child"},{"key":"B12","first-page":"19","article-title":"Genetic alliance monographs and guides","volume-title":"Understanding genetics: A New York, mid-atlantic guide for patients and health professionals","year":"2009"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e20180062","DOI":"10.1590\/1806-3713\/e20180062","article-title":"False-negative newborn screening result for immunoreactive trypsinogen: a major problem in children with chronic lung disease","volume":"45","author":"Lumertz","year":"2019","journal-title":"J Bras Pneumol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1056\/NEJM199710023371403","article-title":"Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin cystic fibrosis neonatal screening study group","volume":"337","author":"Farrell","year":"1997","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00467-013-2712-4","article-title":"Electrolyte abnormalities in cystic fibrosis: systematic review of the literature","volume":"29","author":"Scurati-Manzoni","year":"2014","journal-title":"Pediatr Nephrol"},{"year":"","key":"B16"},{"key":"B17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/adc.88.8.724","article-title":"Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant","volume":"88","author":"Mei-Zahav","year":"2003","journal-title":"Arch Dis Child"},{"key":"B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/tropej\/fmz008","article-title":"Nutritional treatment of a young infant with cystic fibrosis presenting with severe kwashiorkor dermatosis","volume":"65","author":"Sandy","year":"2019","journal-title":"J Trop Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/ced.14438","article-title":"Kwashiorkor-like dermatosis: a rare presentation of cystic fibrosis","volume":"46","author":"Shajil","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B20","article-title":"Kwashiorkor","volume-title":"Statpearls","author":"Benjamin","year":"2021"},{"key":"B21","doi-asserted-by":"publisher","first-page":"17067","DOI":"10.1038\/nrdp.2017.67","article-title":"Severe childhood malnutrition","volume":"3","author":"Bhutta","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcf.2006.05.003","article-title":"\u2018Peeling paint\u2019 dermatitis as a presenting sign of cystic fibrosis","volume":"5","author":"O'Regan","year":"2006","journal-title":"J Cyst Fibros"},{"key":"B23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jama.2020.10429","article-title":"Scaly dermatitis and edema in an irritable child","volume":"325","author":"Boos","year":"2021","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr.07.2011.4475","article-title":"Essential fatty acid deficiency while a patient receiving fat regimen total parenteral nutrition","volume":"2012","author":"Roongpisuthipong","year":"2012","journal-title":"BMJ Case Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00431-002-0982-0","article-title":"Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis\u2013case report and review of the literature","volume":"161","author":"Crone","year":"2002","journal-title":"Eur J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000348261","article-title":"Update on zinc deficiency and excess in clinical pediatric practice","volume":"62","author":"Krebs","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ymgme.2021.08.005","article-title":"Improving outcomes for Colorado's IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs","volume":"134","author":"Martiniano","year":"2021","journal-title":"Mol Genet Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00431-015-2616-3","article-title":"Screening for cystic fibrosis in New York state: considerations for algorithm improvements","volume":"175","author":"Kay","year":"2016","journal-title":"Eur J Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1083155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T18:07:37Z","timestamp":1673028457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1083155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":28,"alternative-id":["10.3389\/fped.2022.1083155"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1083155","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1083155"}}